Hui Zhu

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. doi request reprint Targeting the adrenal gland in castration-resistant prostate cancer: a case for orteronel, a selective CYP-17 17,20-lyase inhibitor
    Hui Zhu
    Department of Solid Tumor Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH 44195, USA
    Curr Oncol Rep 15:105-12. 2013

Collaborators

Detail Information

Publications1

  1. doi request reprint Targeting the adrenal gland in castration-resistant prostate cancer: a case for orteronel, a selective CYP-17 17,20-lyase inhibitor
    Hui Zhu
    Department of Solid Tumor Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH 44195, USA
    Curr Oncol Rep 15:105-12. 2013
    ..Ongoing studies evaluating orteronel in CRPC will further define its safety and role in the management of this disease...